publication date: Dec. 23, 2010

In this issue: 

Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.

ACOR Opens

Connie Mack Joins Washington Office Of Shaw Pittman.

Richard Wood, ICRF, Accepts Appointment At Pittsburgh.

Cancer Groups In Campaign To Draft Pazdur For FDA.

NCI Seeks 150 Advocates For Advice On Plans, Policies.

“Harm-Reduction” Products No Proven, IOM Report Says.

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

Response Oncology Sells Practice Back To Physicians.

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

Download (PDF 645KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.